Pharmaceutical and Medical Law: Legal Analytics and Insights

 

BRACE attorneys continuously monitor regulatory changes in the pharmaceutical and healthcare sectors. This section provides current legal analytics on the circulation of medicinal products, Dietary Supplements, and medical devices, alongside analyses of key court cases and regulatory trends in the life sciences industry.

 

Analytical breakdown of the multi-level licensing requirements and state control mechanisms governing the circulation of controlled substances within the Russian pharmaceutical sector.

Narcotic and Psychotropic Medicinal Products in Russia: Legal Regulation

Structural breakdown of the Russian telemedicine legal framework, highlighting the intersection of healthcare licensing and digital data protection requirements for international providers.

Telemedicine: Legal Regulation in Russia

Strategic overview of the legal evolution regarding medical secrecy and the rights of successors to access healthcare data under Russian Constitutional Court precedents.

Obtaining Medical Documentation Regarding a Deceased Patient

This visual representation delineates the statutory protection periods for clinical trial data versus the permissible windows for generic drug submission and marketing authorization within the EAEU member states.

Data Exclusivity in Russia and the EAEU: Legal Regulation

Strategic overview of the Russian regulatory requirements and judicial precedents governing the restitution of pharmaceutical products within the retail and wholesale sectors.

On the Possibility of Returning Medicinal Products to a Pharmacy

Strategic roadmap of the Russian pharmaceutical track-and-trace ecosystem, illustrating the legal intersection between international manufacturers, regulatory authorities, and serialization standards.

Mandatory Labeling of Medicinal Products: Key Stages and Implementation Specifics

Strategic overview of the Russian regulatory landscape governing off-label prescriptions, highlighting the intersection of clinical guidelines and administrative liability for pharmaceutical entities.

Legal Issues Regarding Off-Label Use of Medicinal Products

A strategic overview of the regulatory workflow required for the seamless transfer of marketing authorisation, highlighting critical compliance checkpoints for international pharmaceutical holders.

Transfer of Marketing Authorisation

Comparative overview of regulatory frameworks governing off-label drug administration and liability protocols across Tier 1 jurisdictions.

Use of Off-label Medicines in the Russian Federation and Abroad

Comparative analysis of the centralized and decentralized registration procedures for pharmaceutical products within the unified EAEU regulatory framework.

Registration of Medicines in Russia and the EAEU: Legal Guide

E-mail
info@brace-lf.com

Send us a request with a detailed description of the issue.

Our phone
+7 (495) 147-11-03

Contact us by phone.

Clients & Partners

65.png
68.png
69.png
73.png
75.png
fitera.jpg
imko.png
logo.png
Logo_RED_RGB_Rus.png
logo_SK_2.png